For instance, the lncRNA MEG3 level was found to be lower in patients with stage III−IV NFPA than those with stage I−II, with the former displaying a higher invasiveness than the latter, while overexpression of MEG3 inhibited the migration and invasion of PA tumor cells.37 The gene discussed is MEG3; the disease is neoplasm.